Touchstone Unveils Customizable Digital Hall of Fame for K-12 and Colleges

Touchstone Digital Solutions has launched a fully customizable Interactive Digital Hall of Fame platform for K–12 schools, colleges, and athletic programs. Replacing outdated plaques and trophy cases, the cloud-based system features touchscreen displays, dynamic content like 3D virtual trophy cases, interactive yearbooks, and multimedia-rich Hall of Fame profiles—all designed with Emmy-nominated UI/UX.

August 5, 2025, Bedford, NH — Being a leader in immersive and customized digital recognition systems, Touchstone Digital Solutions announces their fully customizable Interactive Digital Hall of Fame platform targeted specifically for K-12 schools, colleges, and athletic organizations. Their ready to use solution replaces static trophy cases and aging plaques with the kind of dynamic touchscreen display that breathes artistic life into institutional history through Emmy-nominated UI/UX design and cutting-edge software.

Legacy platforms can't compete with Touchstone when it comes to modern recognition systems. However, Touchstone came along at a crucial time, when schools across the country are looking for new, low-cost ways to honor their graduates and encourage current students to look at their academic and athletic accomplishments.  Touchstone is based in the cloud and provides unlimited branding choices with real-time updates, access that is accessible to everyone with no extra maintenance or hidden fees.

From Concept to Campus: A Design-First Approach

Initially, Touchstone processes a collaborative consultation where the story of each institution is mapped, taking into account culture and visual identity. Then a team of Emmy award-nominated designers and software engineers develops a digital environment particularly crafted for and integrated perfectly with the institution's existing building, colors, and logo. Thus, a live display remains open, growing alongside the institution, recognizing academic milestones, or honoring that legendary coach.

Some interactive display possibilities of different content on the platform include:

• Automatic updates with dynamic team rosters and records.

• Multimedia rich Hall of-Fame profiles with photos, videos, and career highlights.

• Virtual trophy cases in 3D with really neat texture mapping.

• Animated digital donor walls honoring contributors via animated timelines.

• Interactive yearbooks that allow alumni to relive memories on their touchscreens.

 

Scalable, Future-Proof Technology

Touchstone is a platform that works on any device and never locks material away from any screen, no matter how big it is, a 10-inch tablet or an 85-inch 4K TV.  Automatic software updates add new features, and material suggestions based on AI help institutions keep their archives up to date.  A support team that is available 24 hours a day, seven days a week gives staff training and continued technical help that is needed for long-term success.

Pricing tiers accommodate institutions of all sizes, from starter packages for single teams to enterprise opportunities for university-wide rollouts. All hardware packages include premium displays, wall-mount installations, and wrap customizations that tie in with school branding.

 

Schedule a Demo: See Legacy Come to Life

Schools and Universities can set up any kind of demo, either in person or online, at no cost to look at other parts of the tool.  Stakeholders will be guided through a live simulation of the platform that will show how the system can turn lobbies and gyms into heritage experience centers.

 

About Touchstone Digital Solutions

Touchstone Digital Solutions makes fully customized interactive digital recognition platforms for schools and other educational institutions. The company offers digital record boards, digital yearbooks, interactive Hall of Fame displays, athletic program showcases, virtual trophy cases, and digital donor walls. Touchstone Digital Solutions changes the way institutions are recognized by using cutting-edge touchscreen technology and immersive multimedia experiences. They are known for their Emmy-nominated UI/UX graphic design and their design-first development approach. 

Innovative Display Calibration Achieved: Introducing the QUBYX S1 Smart Sensor with Embedded Software

 Wilmington, DE – May 24, 2025 –  QUBYX proudly announces the launch of its groundbreaking new product, the QUBYX S1 Smart Sensor. Designed specifically for integration into displays with embedded software, this state-of-the-art sensor empowers display manufacturers to achieve professional-grade quality while reducing R&D investment and accelerating time-to-market.

The QUBYX S1 Smart Sensor features a highly compact, unobtrusive design that fits seamlessly into adisplay’s frame without compromising aesthetics or performance. Behind the scenes, the embedded software continuously verifies display performance and recalibrates in real time. This “set and forget”system delivers full DICOM calibration right out of the box—ensuring optimal display quality without any manual recalibration or active maintenance.

Key Features & Benefits:

• Seamless Integration: With its small form factor, the sensor can be effortlessly integrated into the display frame, preserving the device’s sleek design while delivering superior performance.

• Unmatched Precision: Leveraging advanced measurement technology and sophisticated calibration algorithms, the S1 Smart Sensor offers exceptional precision. This ensures that every pixel is calibrated to meet the stringent standards required in professional and medical imaging environments.

• Continuous, Automatic Calibration: Operating in the background, the embedded software continuously monitors display performance and automatically triggers recalibration as needed,providing lasting quality assurance.

• Full DICOM Calibration Compliance: Engineered to meet industry standards, the sensor delivers full DICOM calibration immediately upon installation—a crucial benefit for professional and medical applications.

• Reduced R&D Cost & Accelerated Time-to-Market: By streamlining display calibration andquality assurance processes, manufacturers can cut costs and launch professional displays more rapidly.

Integrated PerfectLum Quality Assurance Suite: Seamlessly integrated with QUBYX’sPerfectLum application, the system offers advanced display profiling, acceptance testing, and constancy evaluations in line with stringent medical QA standards such as AAPM TG18, AAMPTG270, DIN 6868-157, NYPDM, and others.

"At QUBYX, our mission is to simplify the complexities of display calibration," said Marc Leppla,Director of QUBYX. "The S1 Smart Sensor revolutionizes the display design process by enabling a seamless, automated calibration that meets the highest industry standards. We are confident that this breakthrough will help our partners significantly reduce development costs and expedite the launch of high-quality professional displays."

For further details—including technical specifications, instructional materials, and partnership opportunities—please visit the dedicated product page:https://qubyx.com/qubyx-smartsensor-s1/

About QUBYX

QUBYX is a leading innovator in the fields of medical imaging and color management, delivering advanced remote display management, calibration, and quality assurance software for displays, projectors, andother visual reproduction hardware. With an unwavering commitment to excellence, QUBYX ensures that imaging devices consistently meet the stringent standards demanded by professionals in the medical, defense, and creative industries. Headquartered in Wilmington, DE, QUBYX continues to pioneer solutions that set new benchmarks indisplay technology.

JAMining Reshapes Passive Crypto Earnings as Bitcoin Crosses $97K and Market Hits $3.1 Trillion

 JAMining launches fixed-income cloud mining contracts, offering secure, passive crypto earnings as Bitcoin surges past $97K and the market hits $3.1 trillion.

London, UK – May 5, 2025 – As Bitcoin surges past $97,000 and the global cryptocurrency market capitalization reaches $3.1 trillion, JAMining, a leading UK-based cloud mining platform, is redefining passive crypto income with its newly launched fixed-income mining contracts. These offerings provide investors with predictable daily returns, eliminating the need for expensive hardware or technical expertise.

JAMining's platform is regulated by the UK Financial Conduct Authority (FCA), ensuring a secure and compliant environment for investors. The company's advanced AI-driven mining strategies and global data center deployment allow for optimized performance and efficient energy use, including the integration of renewable energy sources like solar and wind power. ​

To lower the entry barrier for new users, JAMining offers a $100 bonus upon registration, which can be used to start mining immediately. This initiative allows users to experience the platform's features without any upfront investment. ​

JAMining's infrastructure utilizes industry-leading hardware from Bitmain and NVIDIA, while renewable energy sources like solar and wind power ensure environmentally friendly operations. The company operates over 100 global data centers across Eastern Europe, North America, the Middle East, and South America.

"Our mission is to democratize access to cryptocurrency mining," said a JAMining spokesperson. "​By offering fixed-income contracts and leveraging cutting-edge technology, we enable investors of all levels to participate in the crypto economy securely and profitably."​

Key Features of JAMining's Cloud Mining Contracts:

• FCA-regulated platform ensuring investor protection

• Fixed daily returns with transparent contract terms

• No hardware purchase or technical setup required

• AI-optimized mining operations across global data centers

• Utilization of renewable energy sources for sustainable mining

As Bitcoin continues its upward trajectory, reaching an all-time high of $108,000 in December 2024, JAMining's fixed-income contracts provide a timely opportunity for investors to capitalize on the cryptocurrency market's growth. ​

For more information, visit www.jamining.com or contact info@jamining.com.​

About JAMining

Founded in 2004 and headquartered in the UK, JAMining is a premier cloud mining platform committed to providing secure, efficient, and accessible cryptocurrency mining solutions. With a focus on regulatory compliance and technological innovation, JAMining empowers investors worldwide to participate in the digital asset economy. ​

Lakshmi Finance Center: Jonathan Dale Benton Oversees Engineering Milestone with TradeGenius AI 4.0 Launch

 Lakshmi Finance Center reveals the full-scale deployment of TradeGenius AI 4.0, marking a pivotal advancement in adaptive systems architecture, collaborative model design, and large-scale intelligent automation under the leadership of Jonathan Dale Benton.

San Diego, California, US., April 11, 2025 –  Lakshmi Finance Center today announced the official launch of TradeGenius AI 4.0, a transformative upgrade to its artificial intelligence platform engineered for high-speed, high-volume decision optimization across complex systems. Led by founder Jonathan Dale Benton, the release reflects years of architectural refinement and interdisciplinary collaboration aimed at advancing the state of modular intelligence and scalable autonomous frameworks.

TradeGenius AI 4.0 introduces a restructured core built to accommodate contextual reasoning, neural pattern recalibration, and flexible task sequencing—all operating in a continuously adaptive cycle. The system’s latest capabilities allow for autonomous parsing of real-time information from heterogeneous environments, simulating parallel decision-making scenarios at industrial scale.

Unlike earlier versions, which operated as semi-modular tools designed for specific logic automation tasks, TradeGenius AI 4.0 represents a leap toward general-purpose adaptive frameworks. It processes inputs through a hybrid engine combining reinforcement learning, natural language processing, and temporal feedback controls. This enables the platform to shift strategies in milliseconds based on real-world data distortions, model anomalies, or user-defined thresholds.

“TradeGenius AI 4.0 is not just a system update—it’s a complete architectural rethinking of what a self-evolving AI engine should be,” said Jonathan Dale Benton, speaking at the Lakshmi Engineering Conference. “It blends performance, abstraction, and reasoning to deliver adaptable intelligence that can grow with the problems it encounters.”

The system features a new logic-scripting interface built on natural language prompts, giving non-engineering personnel the ability to define custom model rules without manually coding procedural algorithms. These rules are then interpreted by a translation engine that maps intent to function, creating deployable workflows without traditional programming constraints. The innovation is designed to democratize interaction with intelligent systems and reduce technical bottlenecks in cross-functional environments.

In the backend, TradeGenius AI 4.0 leverages distributed GPU clusters for real-time inferencing, supported by an integrated memory bank that stores context history, behavioral variances, and response trees. This design ensures the engine not only reacts quickly to external inputs but also “remembers” how it has responded to similar past conditions—enabling preemptive scenario mapping and model correction.

The system's rollout follows a multi-year roadmap of experimentation, field trials, and modular testing. Earlier iterations—TradeGenius AI 1.0 through 3.0—focused respectively on decision support tools, programmable agent behavior, and task-focused neural learning. Version 4.0 synthesizes all prior capabilities into a cohesive framework while introducing new dimensions of real-time generalization and outcome prioritization.

The engineering team, composed of AI architects, systems designers, cognitive modelers, and operations engineers, worked in agile clusters to isolate problem sets and simulate edge-case failures prior to the full deployment. Collaborations with external technical advisors from academic research labs and robotics groups also informed the system’s data ingestion strategy and priority weighting protocols.

Looking forward, Lakshmi Finance Center plans to expand the core architecture of TradeGenius AI 4.0 for use in simulation environments, synthetic data training models, and high-density human-machine collaboration systems. A research track has also been opened to explore interpretability frameworks that allow end-users to trace how decisions are made within the adaptive network—a key concern in regulatory and safety-critical domains.

With the release of TradeGenius AI 4.0, Lakshmi Finance Center cements its role as a leader in real-world AI system deployment. The milestone reflects not only a technical evolution but also a cultural commitment to transparency, modularity, and inclusive access to next-generation automation tools.

The full documentation suite for TradeGenius AI 4.0 is now available for technical partners and research collaborators under Lakshmi Finance Center’s Innovation Access Program.

About Lakshmi Finance Center

Lakshmi Finance Center (LFC) firmly believes that finance is not merely about wealth accumulation—it is a transformative force that can drive social progress, enhance financial literacy, and foster sustainable community development. Founded in 2018, LFC has grown into a leader in financial technology, committed to leveraging cutting-edge AI-driven investment strategies to create a more inclusive, transparent, and responsible financial ecosystem that benefits individuals and society alike.

SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Sepsis, Pulmonary Inflammation and Fibrosis at the Respiratory Innovation Summit (RIS) and American Thoracic Society (ATS) International Conference 2025

 SignaBlok will present groundbreaking positive preclinical data detailing therapeutic activity of its leading macrophage-restricted TREM-1 inhibitor in experimental sepsis, acute respiratory distress syndrome (ARDS), and pulmonary fibrosis (PF) at the RIS and ATS Conference in San Francisco, California from May 16-21, 2025.

Shrewsbury, MA, March 24, 2025 – SignaBlok, Inc., a preclinical stage biotechnology company pioneering first-in-class, new mechanism-based peptide therapies for multiple diseases, today announced it will present positive preclinical data detailing therapeutic activity of its leading macrophage-restricted TREM-1 inhibitor in experimental sepsis, acute respiratory distress syndrome (ARDS), and pulmonary fibrosis (PF) at the RIS and ATS Conference in San Francisco, California from May 16-21, 2025.

Details on SignaBlok’s upcoming 2025 RIS and ATS poster presentations are as follows:

• In septic animals, TREM-1 blockade by SignaBlok's first-in-class macrophage-restricted TREM-1 inhibitor protects from death with the level of protection not declining at delayed treatment times

• In rats, macrophage-restricted TREM-1 blockade significantly reduces lipopolysaccharide (LPS)-induced neutrophil accumulation in the lungs when injected after, but not before, LPS challenge

• In mice with bleomycin-induced pulmonary fibrosis,TREM-1 blockade reduces the rate of progression and reverses fibrosis in the prevention and treatment models

• Data highlight potential of SignaBlok’s SCHOOL technology platform to support clinical development of TREM-1 drug with minimal risk of failure due to a new mechanism of action

Respiratory Innovation Summit:
Poster Title: Sepsis: Understanding Nature. Solving the Inflammation Puzzle. Saving Lives.
Presenter: Alexander B. Sigalov, Ph.D. (SignaBlok President and Principal Investigator)
Date / Time: Friday May 16, 2025 2 PM - Saturday May 17, 2025, 6 pm ATS International Conference:
Poster Title: Ligand-Independent TREM-1 Blockade Ameliorates Pulmonary Inflammation and Fibrosis
Presenter: Alexander B. Sigalov, Ph.D. (SignaBlok President and Principal Investigator)
Abstract Presentation Number: 9150
Session: A22 – Break on through: Airway epithelial barrier in inflammation and injury
Date / Time: Sunday May 18, 2025, 9:15 am – 11:15 am

About TREM-1
Triggering receptor expressed on myeloid cells 1 (TREM-1) serves as an inflammation amplifier. As such, TREM-1 is involved in the pathogenesis of sepsis, ARDS, PF, and other inflammatory pathologies. Clinical targeting of TREM-1 is challenging due to multiple known and still unidentified TREM-1 ligands.

About SignaBlok
SignaBlok, Inc. is a Massachusetts-based biotechnology company founded in 2009 to develop innovative, first-in-class therapeutics for targeted treatment of inflammation-associated diseases through the use of two key SignaBlok's proprietary technologies: 1) new mechanism-based approach to inhibition of cell receptors by using innovative, ligand-independent inhibitory peptides (the so-called SCHOOL peptides, the abbreviation coming from the "Signaling Chain HOmoOLigomerization" model of immune signaling); and 2) nature-inspired, multifunctional nanotechnology for targeted drug and/or imaging agent delivery to macrophages. Additional information about SignaBlok is available at www.signablok.com.

Signablok, Inc. To Present Preclinical Data on Trem-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research Annual Meeting 2025

 SignaBlok, Inc. will present groundbreaking preclinical data on targeting innate inflammation for the treatment of hard-to-treat cancers. In combination with standard-of-care chemotherapy, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, prevents cancer recurrence, improves complete response rate and survival in experimental pancreatic cancer. In combination with anti-PD-L1 treatment, it overcomes pancreatic cancer resistance to immunotherapy.

Shrewsbury, MA, USA, March 23, 2025 –  SignaBlok, Inc.. a preclinical stage biotechnology company pioneering first-in-class, new mechanism-based peptide therapies for multiple diseases, today announced it will present positive preclinical oncology data on the company's leading macrophage-restricted TREM-1 inhibitor at the 2025 AACR Annual Meeting to be held in Chicago, Illinois from April 25-30, 2025.

Details on SignaBlok’s upcoming 2025 AACR Annual Meeting poster presentation are as follows:

• In experimental pancreatic cancer, SignaBlok's first-in-class macrophage-restricted TREM-1 inhibitor:
− prevents cancer recurrence, improves complete response rate and survival, when administered after, but not concurrently with, standard-of-care chemotherapy

− reverses immunosuppression and overcomes cancer resistance to anti-PD-L1 immunotherapy

• Rodent studies indicate that SignaBlok's TREM-1 inhibitor is safe and well-tolerable

• Data highlight potential of SignaBlok’s SCHOOL technology platform to support clinical development of TREM-1 drug with minimal risk of failure due to a new mechanism of action

• Presented results have important clinical implications in the treatment of patients with not only pancreatic cancer, but also other inflammation-associated, hard-to-treat solid tumors

Poster Title: Timely resolution of TREM-1-mediated inflammation after chemotherapy improves complete response rate and survival in experimental pancreatic cancer
Presenter: Alexander B. Sigalov, Ph.D. (SignaBlok, Inc.; President and Principal Investigator)
Abstract Presentation Number: LB128
Poster Session 52: Monday April 28, 2025, 9:00 am – 12:00 pm

About pancreatic cancer (PC)
PC is the third leading cause of cancer-related death in the US. Despite recent advances, the 5-year survival rate for all stages combined is as low as 13%, necessitating the development of new approaches.

About TREM-1
Triggering receptor expressed on myeloid cells 1 (TREM-1) serves as an inflammation amplifier. As such, TREM-1 is critically involved in the pathogenesis of multiple cancer types, sepsis, rheumatoid arthritis, acute respiratory distress syndrome, scleroderma, atherosclerosis, and other inflammatory pathologies. Clinical targeting of TREM-1 is challenging due to multiple known and still unidentified TREM-1 ligands.

About SignaBlok
SignaBlok, Inc. is a Massachusetts-based biotechnology company founded in 2009 to develop innovative, first-in-class therapeutics for targeted treatment of inflammation-associated diseases through the use of two key SignaBlok's proprietary technologies: 1) new mechanism-based approach to inhibition of cell receptors by using innovative, ligand-independent inhibitory peptides (the so-called SCHOOL peptides, the abbreviation coming from the "Signaling Chain HOmoOLigomerization" model of immune signaling); and 2) nature-inspired, multifunctional nanotechnology for targeted drug and/or imaging agent delivery to macrophages. Additional information about SignaBlok is available at www.signablok.com.

Acclaimed Author A.M. Berkowitz Featured in Reader’s House Magazine

 Renowned children’s author A.M. Berkowitz has been featured in the latest issue of Reader’s House Magazine, London’s premier literary gateway.

 

London, UK, March 8, 2025 – Renowned children’s author A.M. Berkowitz has been featured in the latest issue of Reader’s House Magazine, London’s premier literary gateway.

Recognised for her exceptional storytelling and ability to inspire young readers, Berkowitz was also honoured with the Editor’s Choice Award of Literary Excellence, a prestigious accolade presented to a select group of outstanding authors.

Reader’s House Magazine, which is available in over 190 countries and thousands of stores including Amazon, Barnes & Noble, Walmart, and Waterstones, praised both Berkowitz and her literary works. Best known for the Gigglet the Happy Little Piglet series, her stories spark imagination, joy, and a love for reading among children worldwide.

In an exclusive interview, Berkowitz shared her heartfelt journey from a corporate career and operatic background to becoming a celebrated children’s author. Reflecting on her transition, she said: “I discovered my passion for writing children’s books was undeniable and would happen whether or not it was in ‘my plan.’”

The interview delves into the inspiration behind her beloved character, Gigglet, whose adventures have captivated young audiences. Berkowitz revealed that the idea for Gigglet came to her unexpectedly:

“One morning, I received a spam email that said ‘Lit Gadget’ in the subject line, but my brain read it as ‘Gigglet.’ I laughed out loud and thought, ‘That doesn’t say Gigglet, but what if it did?’ And from there, a whole world opened up.”

Berkowitz’s books are more than just stories—they encourage creativity, fun, and a deep sense of connection. Speaking about her mission, she shared: “The most important thing to remember when reading the Gigglet books is to be in the moment, have fun, follow your bliss, and ‘GET YOUR GIGGLE ON.’”

With multiple new books and exciting projects on the horizon, including the expansion of the Gigglet series, Berkowitz continues to inspire children and families worldwide.
The full interview is available in Reader’s House Magazine, Issue 49 at https://readershouse.co.uk/issue-49.



About A.M. Berkowitz
A.M. Berkowitz is a celebrated children’s author known for her imaginative and heartwarming storytelling. A former operatic mezzo-soprano and corporate professional, she found her true passion in writing, creating the beloved Gigglet the Happy Little Piglet series. Through her books, Berkowitz aims to inspire joy, creativity, and a love for reading in children worldwide. Visit her website at www.ambkidsbooks.com for more information on her work and upcoming projects.